Skip to main content
Top
Published in: Rheumatology International 5/2003

01-09-2003 | Case Report

Paraneoplastic eosinophilic fasciitis: a case report

Authors: Sharon E. Jacob, Rashmi Lodha, Jonathan J. Cohen, Paolo Romanelli, Robert S. Kirsner

Published in: Rheumatology International | Issue 5/2003

Login to get access

Abstract

A 60-year-old white woman with polycythemia rubra vera post splenectomy in November 2001 was found to have peripheral white blood cell counts increasing over 3 months. Cytogenetics revealed trisomy of chromosomes 8 and 9, and bone marrow biopsy showed hypercellular, fibrotic bone marrow consistent with myelofibrosis of polycythemia rubra vera. Two months later, the patient developed acute swelling and pain in her lower extremities. The clinical symptoms along with confirmatory histology supported the diagnosis of eosinophilic fasciitis. This is the first reported case in the English literature of an association between polycythemia vera and eosinophilic fasciitis.
Literature
1.
go back to reference Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17:221–231PubMed Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17:221–231PubMed
2.
go back to reference Barnes L, Rodnan GP, Medsger TA, Short D (1979) Eosinophilic fasciitis: a pathologic study of twenty cases. Am J Pathol 96:493–507PubMed Barnes L, Rodnan GP, Medsger TA, Short D (1979) Eosinophilic fasciitis: a pathologic study of twenty cases. Am J Pathol 96:493–507PubMed
3.
go back to reference Chan LS, Hanson CA, Cooper KD (1991) Concurrent eosinophilic fasciitis and cutaneous T-cell lymphoma: eosinophilic fasciitis as a paraneoplastic syndrome of T-cell malignant neoplasms? Arch Dermatol 127:862–865 Chan LS, Hanson CA, Cooper KD (1991) Concurrent eosinophilic fasciitis and cutaneous T-cell lymphoma: eosinophilic fasciitis as a paraneoplastic syndrome of T-cell malignant neoplasms? Arch Dermatol 127:862–865
4.
go back to reference Seibold JR, Rodnan GP, Medsger TA Jr, Winkelstein A (1982) Circulating immune complexes in eosinophilic fasciitis. Arthritis Rheum 25:1180–1185PubMed Seibold JR, Rodnan GP, Medsger TA Jr, Winkelstein A (1982) Circulating immune complexes in eosinophilic fasciitis. Arthritis Rheum 25:1180–1185PubMed
5.
go back to reference Hoffman R, Young N, Ershler WB, Mazur E, Gewirtz A (1982) Diffuse fasciitis and aplastic anemia: a report of four cases revealing an unusual association between rheumatologic and hematologic disorders. Medicine 61:373–381PubMed Hoffman R, Young N, Ershler WB, Mazur E, Gewirtz A (1982) Diffuse fasciitis and aplastic anemia: a report of four cases revealing an unusual association between rheumatologic and hematologic disorders. Medicine 61:373–381PubMed
6.
go back to reference Michet CJ Jr, Doyle JA, Ginsburg WW (1981) Eosinophilic fasciitis: report of 15 cases. Mayo Clin Proc 56:27–34PubMed Michet CJ Jr, Doyle JA, Ginsburg WW (1981) Eosinophilic fasciitis: report of 15 cases. Mayo Clin Proc 56:27–34PubMed
7.
go back to reference Tefferi A, Solberg LA Jr, Silverstein MN (2000) A clinical update in polycythemia vera and essential throbocythemia. Am J Med 109:141–149PubMed Tefferi A, Solberg LA Jr, Silverstein MN (2000) A clinical update in polycythemia vera and essential throbocythemia. Am J Med 109:141–149PubMed
Metadata
Title
Paraneoplastic eosinophilic fasciitis: a case report
Authors
Sharon E. Jacob
Rashmi Lodha
Jonathan J. Cohen
Paolo Romanelli
Robert S. Kirsner
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0317-0

Other articles of this Issue 5/2003

Rheumatology International 5/2003 Go to the issue

Letter to the editor

TB or not TB

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine